The S100A8/A9 complex inhibits the activity of matrix metalloproteinases [58] and has been used as a marker for rheumatoid arthritis [59], colorectal cancer, inflammatory bowel disease [60], and periodontitis [61]. This evidence concerns the gene IGKV1D-22 and inflammatory bowel disease.